Skip to content
Search
DONATE
SUBSCRIBE
Follow Us
Facebook
Twitter
Instagram
ACTION ALERTS
Home
Advocacy Info
Resource Center
Legislative Summaries
Safe Harbor Practitioner Exemption Laws
Regulations
Right to Refuse
Health Freedom Information Documents
Workshops and Hearings – Schedules & Materials
Gallery
Newsletters
State Organizations
About
Mission
Board of Directors
Advisory Board
Annual Reports
Contact Us
NHFC
Menu
ACTION ALERTS
Home
Advocacy Info
Resource Center
Legislative Summaries
Safe Harbor Practitioner Exemption Laws
Regulations
Right to Refuse
Health Freedom Information Documents
Workshops and Hearings – Schedules & Materials
Gallery
Newsletters
State Organizations
About
Mission
Board of Directors
Advisory Board
Annual Reports
Contact Us
NHFC
Federal Regulation Information
FDA Homeopathic Products:
NHFA to FDA, March 2018, Formal Comments in response to the FDA proposed Draft Guidance entitled: Drug Products Labeled as Homeopathic: Guidance for FDA Staff and Industry, Docket ID. FDA-2017-D-6580, Food and Drug Administration – Center for Drug Evaluation and Research (CDER) in cooperation with the Center for Biologics Evaluation and Research (CBER), December 2017.
CDC Communicable Disease:
NHFA to CDC, September, 2016, Formal Request for the Withdrawal of the CDC’s Notice of Proposed Rulemaking entitled: Control of Communicable Disease, Docket No. CDC-2016-0068, Department of Health and Human Services, Center for Disease Control and Prevention, August 2016.
FDA New Dietary Ingredients:
NHFA November 2011, Formal Comments in response to the FDA proposed Draft Guidance: “Draft Guidance for Industry; Dietary Supplements: New Dietary Ingredient Notifications and Related Issues; Availability”, Docket No. FDA–2011–D–0376 20, July 2011.
Creating New Laws:
Miller, D, 2009. Creating New Health Care Laws and Regulations, Alternative and Complementary Therapies.
Dietary Supplement Product Labeling:
Miller, D, 2007. Freedom of Speech and Truthful Information in Health Care, Alternative and Complementary Therapies.
CAM and the FDA:
NHFA to FDA, 2007, Formal Comments in response to the FDA proposed Draft Guidance entitled: “Guidance for Industry on Complementary and Alternative Medicine Products and Their Regulation by the Food and Drug Administration” Docket ID. 2006d-0480, Department of Health and Human Services, Food and Drug Administration, December 2006